Patents by Inventor James A. Comer

James A. Comer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human ebola virus species and compositions and methods thereof
    Patent number: 10428314
    Abstract: Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: October 1, 2019
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Jonathan S. Towner, Stuart T. Nichol, James A. Comer, Thomas G. Ksiazek, Pierre E. Rollin
  • HUMAN EBOLA VIRUS SPECIES AND COMPOSITIONS AND METHODS THEREOF
    Publication number: 20180002675
    Abstract: Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
    Type: Application
    Filed: August 28, 2017
    Publication date: January 4, 2018
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Serv
    Inventors: Jonathan S. Towner, Stuart T. Nichol, James A. Comer, Thomas G. Ksiazek, Pierre E. Rollin
  • Human Ebola virus species and compositions and methods thereof
    Patent number: 9790473
    Abstract: Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: October 17, 2017
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Jonathan S. Towner, Stuart T. Nichol, James A. Comer, Thomas G. Ksiazek, Pierre E. Rollin
  • HUMAN EBOLA VIRUS SPECIES AND COMPOSITIONS AND METHODS THEREOF
    Publication number: 20150218525
    Abstract: Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
    Type: Application
    Filed: April 23, 2015
    Publication date: August 6, 2015
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Serv
    Inventors: Jonathan S. Towner, Stuart T. Nichol, James A. Comer, Thomas G. Ksiazek, Pierre E. Rollin
  • Human Ebola Virus Species and Compositions and Methods Thereof
    Publication number: 20120251502
    Abstract: Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
    Type: Application
    Filed: October 26, 2009
    Publication date: October 4, 2012
    Applicant: The Government of the US as Represented by the Secretary of the Dept. of health
    Inventors: Jonathan S. Towner, Stuart T. Nichol, James A. Comer, Thomas G. Ksiazek, Pierre E. Rollin
  • Coronavirus isolated from humans
    Patent number: 7776521
    Abstract: Disclosed herein is a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect a SARS-CoV and detect infections therewith. Immune stimulatory compositions are also provided, along with methods of their use.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: August 17, 2010
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
    Inventors: Paul A. Rota, Larry J. Anderson, William J. Bellini, Michael D. Bowen, Cara Carthel Burns, Raymond Campagnoli, Qi Chen, James A. Comer, Byron T. Cook, Shannon L. Emery, Dean D. Erdman, Cynthia S. Goldsmith, Jeanette Guarner, Charles D. Humphrey, Joseph P. Icenogle, Thomas G. Ksiazek, Richard F. Meyer, Stephan S. Monroe, William Allan Nix, M. Steven Oberste, Christopher D. Paddock, Teresa C. T. Peret, Pierre E. Rollin, Mark A. Pallansch, Anthony Sanchez, Wun-Ju Shieh, Suxiang Tong, Sherif R. Zaki
  • Displaying a live view and captured images in a digital camera
    Publication number: 20080055453
    Abstract: A method for displaying a live view and captured images of a digital camera is provided. In the method, a live view is displayed. A first image of the live view is captured. In response to capturing the first image, the captured first image is displayed. The captured first image is then shifted from view toward a first direction to reveal the live view.
    Type: Application
    Filed: September 5, 2006
    Publication date: March 6, 2008
    Inventors: Amy E. Battles, Sarah J. Schwartz, Geoffrey Dowd, Ben Fineman, Cordell Ratzlaff, Karen E. Williams, James Comer, Benjamin D. Kimbell, Angelica A. Quintana
  • Coronavirus isolated from humans
    Patent number: 7220852
    Abstract: Disclosed herein is a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect a SARS-CoV and detect infections therewith. Immune stimulatory compositions are also provided, along with methods of their use.
    Type: Grant
    Filed: April 12, 2004
    Date of Patent: May 22, 2007
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
    Inventors: Paul A. Rota, Larry J. Anderson, William J. Bellini, Cara Carthel Burns, Raymond Campagnoli, Qi Chen, James A. Comer, Shannon L. Emery, Dean D. Erdman, Cynthia S. Goldsmith, Charles D. Humphrey, Joseph P. Icenogle, Thomas G. Ksiazek, Stephan S. Monroe, William Allan Nix, M. Steven Oberste, Teresa C. T. Peret, Pierre E. Rollin, Mark A. Pallansch, Anthony Sanchez, Suxiang Tong, Sherif R. Zaki
  • Method and apparatus for reduced image capture delay in a digital camera
    Publication number: 20060187313
    Abstract: A digital camera includes a rapid image capture mode in which a combination of automatically selected focus, exposure, aperture, and, optionally, gain settings facilitates capturing a digital image with minimal delay after the shutter button is depressed.
    Type: Application
    Filed: February 22, 2005
    Publication date: August 24, 2006
    Inventors: Amol Pandit, Kevin Allen, James Comer, Oscar Zuniga